Pure Global AI
ANVISA registration 80000230109Active

IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS

ANVISA Registration Number: 80000230109AGILENT TECHNOLOGIES BRASIL LTDAAGILENT TECHNOLOGIES, INC.Risk Class I
Verified
Device names
Technical name
IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS
View exact technical-name matches →
PT: HIBRIDIZAÇÃO IN SITU - REAGENTES COMPLEMENTARES
Commercial name
Anti-FITC-AP CISH Accessory Kit (Dako Omnis)
View exact commercial-name matches →
Risk class
Class I
Registration details
Registration Number
80000230109
Process Number
25351106025202612
CNPJ
03290250000100
Company information
Registration Holder
AGILENT TECHNOLOGIES BRASIL LTDA
Manufacturer
AGILENT TECHNOLOGIES, INC.
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jul 06, 2026
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IN SITU HYBRIDIZATION - COMPLEMENTARY REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 80000230109 and manufactured by AGILENT TECHNOLOGIES, INC.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.